Stephens Inc. AR Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stephens Inc. AR lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,211 shares of the medical equipment provider’s stock after selling 140 shares during the quarter. Stephens Inc. AR’s holdings in Intuitive Surgical were worth $4,034,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Ullmann Wealth Partners Group LLC lifted its holdings in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC lifted its holdings in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares during the period. Daymark Wealth Partners LLC lifted its holdings in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after buying an additional 24 shares during the period. Indiana Trust & Investment Management CO lifted its holdings in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after buying an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC lifted its holdings in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 68,246 shares of company stock valued at $33,839,308. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ISRG. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $506.34 on Friday. The company has a market cap of $180.35 billion, a PE ratio of 81.41, a P/E/G ratio of 4.95 and a beta of 1.39. The business has a 50-day simple moving average of $490.41 and a two-hundred day simple moving average of $447.08. Intuitive Surgical, Inc. has a fifty-two week low of $269.49 and a fifty-two week high of $523.34.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.